News - AMAG Pharmaceuticals, Biotechnology

Filter

Popular Filters

Rainbow Coral seeks place in $84.6 billion biotechnology sector, forming new division; AMAG merger with Allos called off

23-10-2011

Florida, USA-based Rainbow Coral (OTCQB: RBCC) last week announced its intention to move into the discovery…

Allos TherapeuticsAMAG PharmaceuticalsBiotechnologyMergers & AcquisitionsPharmaceuticalRainbow BiosciencesResearch

AMAG Pharma and Allos Thera to merge in $686 million stock deal; Express Scripts to buy Medco

21-07-2011

US drugmakers AMAG Pharmaceuticals (Nasdaq: AMAG) and Allos Therapeutics (Nasdaq: ALTH) entered into…

Allos TherapeuticsAMAG PharmaceuticalsBiotechnologyMergers & AcquisitionsPharmaceutical

Back to top